← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Alternative Treatment for Syphilis
- Institution
- FOX CHASE CHEMICAL DIVERSITY CENTER, INC, PA
- Principal investigator
- Thomas E. Smithgall
- Funding
- $307K
- Duration
- 2024–2025
Moonbase score
Still being scored
Abstract
The objective of this project is to develop a new treatment for Syphilis.
LOADING MOONBASE SCORE
Questions for Fox Chase Chemical Diversity Center, Inc
Fox Chase Chemical Diversity Center, Inc hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of Pittsburgh at PittsburghNot yet scored
Discovery and Development of Allosteric Inhibitors of Src-family Kinases for AML
Thomas E. Smithgall · $186K · 2025–2027
- NIH · University of Pittsburgh at PittsburghNot yet scored
Chemical Biology of HIV-1 Nef
Thomas E. Smithgall · $753K · 2020–2029
- NIH · Fox Chase Chemical Diversity Center, IncNot yet scored
Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders
Allen Bernard Reitz · $1.4M · 2021–2026